FDA shortens interval for Moderna COVID-19 vaccine boosterThe Moderna COVID-19 vaccine booster can be given five months after completion of a primary series of the vaccine to individuals aged 18 years old and older. Walgreens Boots Alliance raises guidance amid strong Q1 resultsWalgreens Boots Alliance beat analysts’ expectations for fiscal first-quarter earnings as customers came to stores for COVID-19 vaccines and tests. CDC recommends COVID-19 booster for adolescents aged 12 to 17 years old The CDC now recommends that adolescents aged 12 to 17 years old should receive a booster shot five months after their initial Pfizer-BioNTech vaccination series. CDC shortens interval for Pfizer’s COVID-19 booster People can now receive an mRNA booster shot five months after completing their Pfizer-BioNTech primary series. FDA expected to expand COVID-19 booster eligibility for children ages 12 to 15 Approval of a COVID-19 booster for children ages 12 to 15 could come in the days to weeks ahead. FDA grants EU authorization for Clinitest Rapid COVID-19 Antigen Self-Test The at-home test from Siemens Healthineers provides another option for testing as more consumers seek early detection. CDC updates and shortens recommended isolation and quarantine period for COVID-19 The change is motivated by science showing that the majority of SARS-CoV-2 transmission occurs early in the course of illness. FDA gives EU authorization for Molnupiravir Molnupiravir received emergency use authorization for mild-to-moderate COVID-19 in adults. Mindful snacking: Consumers are seeking out flavorful and nutritional options Snack producers expand their offerings with healthier products and staples. IRI postpones 2022 Growth Summit Amid the rise in COVID-19, IRI has postponed its Growth Summit until 2023. First Previous 48 49 50 51 52 Next Last
